全文获取类型
收费全文 | 27867篇 |
免费 | 3839篇 |
国内免费 | 181篇 |
专业分类
耳鼻咽喉 | 594篇 |
儿科学 | 578篇 |
妇产科学 | 738篇 |
基础医学 | 3151篇 |
口腔科学 | 598篇 |
临床医学 | 4899篇 |
内科学 | 5285篇 |
皮肤病学 | 657篇 |
神经病学 | 2545篇 |
特种医学 | 1272篇 |
外科学 | 4069篇 |
综合类 | 479篇 |
现状与发展 | 2篇 |
一般理论 | 2篇 |
预防医学 | 2849篇 |
眼科学 | 764篇 |
药学 | 1409篇 |
1篇 | |
中国医学 | 158篇 |
肿瘤学 | 1837篇 |
出版年
2024年 | 95篇 |
2023年 | 524篇 |
2022年 | 254篇 |
2021年 | 585篇 |
2020年 | 689篇 |
2019年 | 493篇 |
2018年 | 967篇 |
2017年 | 950篇 |
2016年 | 1035篇 |
2015年 | 1147篇 |
2014年 | 1279篇 |
2013年 | 1840篇 |
2012年 | 1416篇 |
2011年 | 1360篇 |
2010年 | 1245篇 |
2009年 | 1351篇 |
2008年 | 1331篇 |
2007年 | 1322篇 |
2006年 | 1389篇 |
2005年 | 1308篇 |
2004年 | 1051篇 |
2003年 | 1018篇 |
2002年 | 972篇 |
2001年 | 386篇 |
2000年 | 278篇 |
1999年 | 355篇 |
1998年 | 476篇 |
1997年 | 453篇 |
1996年 | 466篇 |
1995年 | 406篇 |
1994年 | 308篇 |
1993年 | 251篇 |
1992年 | 202篇 |
1991年 | 179篇 |
1990年 | 152篇 |
1989年 | 158篇 |
1988年 | 147篇 |
1987年 | 121篇 |
1986年 | 117篇 |
1985年 | 128篇 |
1984年 | 139篇 |
1983年 | 112篇 |
1982年 | 127篇 |
1981年 | 134篇 |
1980年 | 79篇 |
1933年 | 97篇 |
1932年 | 93篇 |
1931年 | 82篇 |
1930年 | 83篇 |
1926年 | 81篇 |
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
1.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
Well‐being,health and fitness of children who use wheelchairs: Feasibility study protocol to develop child‐centred ‘keep‐fit’ exercise interventions
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
4.
5.
6.
目的 探讨在苯妥英钠(Phenytoin,PHT)促进大鼠牙周膜干细胞(Rat periodontal ligament stem cells,rPDLSCs)、大鼠骨髓间充质干细胞(Rat Bone Marrow Mesenchymal Stem Cells,rBMMSCs)黏附于牙骨质过程中,整合素α5β1(Integrin α5β1)起到的作用。方法 提取大鼠BMMSCs和PDLSCs,培养并纯化。通过细胞鉴定后,将获得的两种细胞各分为4组:40 mg/L PHT处理组、40 mg/L PHT+整合素α5抗体处理组、40 mg/L PHT+整合素β1抗体处理组、PBS处理组,每组细胞放入置有牙骨质片的96孔板处理4 h后,检测黏附于牙骨质片上的细胞量并做以比较。最后,利用qRT-PCR和Western blot检测40 mg/L PHT组与对照组细胞的整合素α5、β1亚基的mRNA与蛋白表达量。结果 40 mg/L PHT可促进rBMMSCs及rPDLSCs黏附于牙骨质片,加入整合素α5、β1抗体后,均明显抑制了40 mg/L PHT对rBMMSCs、rPDLSCs黏附于牙骨质的促进作用(P<0.01)。qRT-PCR、Western-blot结果显示PHT处理组的整合素α5、β1亚基表达量高于空白对照组(P<0.05)。结论 40 mg/L PHT能促进rBMMSCs、rPDLSCs黏附于牙骨质,该作用与整合素α5β1的表达上调密切相关。 相似文献
7.
8.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献9.
10.